All Posts
Clinical practice guideline: exercise and lifestyle in chronic kidney disease.
24 Feb, 2022 | 10:15h | UTCClinical practice guideline exercise and lifestyle in chronic kidney disease – BMC Nephrology
ASCO Report: Use of Biosimilar Medications in Oncology.
24 Feb, 2022 | 10:08h | UTCUse of Biosimilar Medications in Oncology – JCO Oncology Practice
News Release: New ASCO Report Clarifies Potential Value and Utility of Biosimilars in Oncology – ASCO Daily News
SMFM Guidance: Use of analgesia and anesthesia for maternal-fetal procedures.
24 Feb, 2022 | 10:10h | UTC
Review: Enhanced recovery after surgery for major orthopedic surgery.
24 Feb, 2022 | 10:01h | UTCSee also: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)
Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review.
24 Feb, 2022 | 10:11h | UTC
M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.
24 Feb, 2022 | 10:02h | UTCSecondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (free registration required)
Related:
RCT: Cytoreductive surgery for relapsed ovarian cancer.
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies.
24 Feb, 2022 | 10:05h | UTC
USPSTF Draft Statement: Statin use for the primary prevention of cardiovascular disease in adults.
23 Feb, 2022 | 10:45h | UTCCommentary: USPSTF Updates Guidance on Statins for Primary Prevention of CVD – HealthDay
A review of mucinous cystic and intraductal neoplasms of the pancreatobiliary tract: recent advances.
24 Feb, 2022 | 09:59h | UTC
WHO/UNICEF: More than half of parents and pregnant women exposed to aggressive formula milk marketing.
23 Feb, 2022 | 10:42h | UTCCommentary: Aggressive’ marketing of formula milk flouts code, warns WHO as it urges curbs – The Guardian
Commentary on Twitter
"We have been targeted with marketing from formula milk companies."
Over half of parents & pregnant women exposed to formula milk marketing, violating international standards and harming child health
-🆕 WHO, @UNICEF survey➡️ https://t.co/86Bf69PSeK#EndExploitativeMarketing pic.twitter.com/BuhQPgM3OX
— World Health Organization (WHO) (@WHO) February 22, 2022
AHA Scientific Statement: Strategies to reduce low-value cardiovascular care.
23 Feb, 2022 | 10:43h | UTCNews Release: Do you really need that test? New statement highlights need to reduce “low-value” heart care – American Heart Association
WHO: Here are the 16 ‘best buys’ to tackle non-communicable diseases.
23 Feb, 2022 | 10:19h | UTCWHO: Here Are The 16 ‘Best Buys’ To Tackle Non-Communicable Diseases – Forbes
Original Report: WHO Report | Saving lives, spending less: the case for investing in noncommunicable diseases.
RCT: Sublingual dexmedetomidine reduces mild to moderate acute agitation in patients with bipolar disorder.
23 Feb, 2022 | 10:18h | UTCEffect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Sublingual Dexmedetomidine as a Potential New Treatment for Agitation – JAMA (free for a limited period)
Commentary on Twitter
Randomized clinical trial found sublingual #dexmedetomidine at a dose of 180 μg or 120 μg reduced mild to moderate agitation in patients with #bipolar disorder. https://t.co/1VK2e15F7s pic.twitter.com/0oHw6eVMIP
— JAMA (@JAMA_current) February 22, 2022
AGA Guideline on systemic therapy for hepatocellular carcinoma.
23 Feb, 2022 | 10:14h | UTCAGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma – Gastroenterology
Consensus Paper: Clinical applications of cardiac computed tomography.
23 Feb, 2022 | 10:12h | UTC
Large registry-based study in the U.S. suggests infertility treatments are associated with increased risks for pregnancy and vascular complications.
23 Feb, 2022 | 10:16h | UTCNews Release: Common infertility treatments may increase risks for pregnancy, vascular complications – American Heart Association
Commentary: Infertility treatments raise risk of heart and pregnancy complications, study finds – CNN
Consensus Paper: Non-invasive imaging in coronary syndromes.
23 Feb, 2022 | 10:10h | UTC
ASCO Guideline Update: Adjuvant systemic therapy and adjuvant radiation therapy for stage I-IIIA completely resected non–small-cell lung cancer.
23 Feb, 2022 | 10:08h | UTC
Commentary on Twitter
‼️ Just published in #JCO: @ASCO rapid guideline update on adjuvant systemic therapy & adjuvant radiation therapy for stage I to IIIA completely resected #NSCLC 🫁 https://t.co/OheQi7Bi97 #lcsm #radonc pic.twitter.com/Dax2orUXZy
— Journal of Clinical Oncology (@JCO_ASCO) February 15, 2022
Opinion | Controlling the control arm in metastatic castration-resistant prostate cancer trials: best standard of care or the minimum standard of care?
23 Feb, 2022 | 10:03h | UTC
Systematic Review: Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer.
23 Feb, 2022 | 10:05h | UTC
M-A: Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections.
23 Feb, 2022 | 10:07h | UTC
Review: Pruritus in pregnancy.
23 Feb, 2022 | 09:59h | UTCPruritus in Pregnancy – American Journal of Clinical Dermatology
Diagnostic test interpretation: hypernatremia.
23 Feb, 2022 | 10:02h | UTCHypernatremia – JAMA (free for a limited period)
Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches.
23 Feb, 2022 | 10:01h | UTC
A Review of existing therapies for Actinic Keratosis: current status and future directions.
23 Feb, 2022 | 09:58h | UTC